Cost Consequences of the 340B Drug Discount Program
نویسندگان
چکیده
منابع مشابه
The 340b drug discount program: oncology's optical illusion.
Figure: "My Wife and My Mother-in-Law" by William E. Hill (1915). High-quality oncology care can be very expensive, and often entails resourceintensive therapy given over moderate to prolonged periods of time. Patients who either do not have insurance or are underinsured can have difficulty accessing therapy. The 340b program was instituted approximately 2 decades ago with the intent of improvi...
متن کاملThe 340B Discount Drug Program At Ozarks Medical Center: An Economic Stimulus Plan for Missouri.
profit hospital serves approximately 160,000 residents, spread over 11 counties, including some of the poorest in the U.S. Nearly one-fourth of the residents in its five core service counties live below the poverty line. The next closest major medical center is in Springfield, Mo., 90 miles away. Despite its relatively small size, Ozarks Medical offers the clinical capability of larger institut...
متن کاملSubsidizing Consolidation? Unintended Consequences of a Federal Drug Discount Program∗
Many salient profit incentives that health care providers face stem from government policies. We investigate hospital response to the 340B Drug Discount Program, a federal policy that substantially increases profitability of drug administration for about 45% of hospitals by entitling them to discounts of between 20% and 50% on drugs. Our primary empirical strategy is a fuzzy regression disconti...
متن کاملHospital Group Wants to Expand Section 340B Drug Purchase Program.
the House Ways and Means Committee on September 23. He explained that this would allow the hospitals to further stretch their limited resources and relieve them of the burden of carrying two separate inventories and pricing structures for inpatient and outpatient drugs. Theoretically, the Ways and Means Committee, in conjunction with Energy and Commerce and Senate Finance, could initiate author...
متن کاملPolicy Statement on the 340B Drug Pricing Program by the American Society of Clinical Oncology.
Congress established Section 340B of the Public Health Service Act—commonly referred to as the 340B Drug Pricing Program—in 1992.1 The 340B Drug Pricing Program requires manufacturers to provide substantial discounts for sales of covered drugs to covered entities as a prerequisite to qualifying for Medicaid reimbursement. Covered hospitals and other covered entities must limit the use of discou...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JAMA
سال: 2013
ISSN: 0098-7484
DOI: 10.1001/jama.2013.4156